Unrecognized Tax Benefits in USD of Corvus Pharmaceuticals, Inc. from Q4 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Corvus Pharmaceuticals, Inc. quarterly Unrecognized Tax Benefits history and change rate from Q4 2015 to Q3 2025.
  • Corvus Pharmaceuticals, Inc. Unrecognized Tax Benefits for the quarter ending 30 Sep 2025 was $0.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

Corvus Pharmaceuticals, Inc. Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $0 $0 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $0 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q4 2024 $13,136,000 +$313,000 +2.4% 31 Dec 2024 10-K 25 Mar 2025 2024 FY
Q3 2024 $0 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q4 2023 $12,823,000 +$103,000 +0.81% 31 Dec 2023 10-K 25 Mar 2025 2024 FY
Q4 2022 $12,720,000 +$216,000 +1.7% 31 Dec 2022 10-K 25 Mar 2025 2024 FY
Q4 2021 $12,504,000 +$347,000 +2.9% 31 Dec 2021 10-K 25 Mar 2025 2024 FY
Q4 2020 $12,157,000 +$10,272,000 +545% 31 Dec 2020 10-K 19 Mar 2024 2023 FY
Q4 2019 $1,885,000 +$81,000 +4.5% 31 Dec 2019 10-K 28 Mar 2023 2021 FY
Q4 2018 $1,804,000 +$585,000 +48% 31 Dec 2018 10-K 10 Mar 2022 2021 FY
Q4 2017 $1,219,000 +$615,000 +102% 31 Dec 2017 10-K 25 Mar 2021 2020 FY
Q4 2016 $604,000 +$469,000 +347% 31 Dec 2016 10-K 09 Mar 2020 2019 FY
Q4 2015 $135,000 31 Dec 2015 10-K 07 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.